orally active beta-1,3-glucan synthesis inhibitor eff. in fungal infect. model, discont. for alt. from semisynthetic mod. of enfumafungin Bioorg. Med. Chem. Lett., Jun. 19, 2020 Merck & Co., Kenilworth, NJ / Scynexis